SEARCH   
MEMBER LOGIN    

Brand Name Pharmaceutical Manufacturing in the US: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Brand Name Pharmaceutical Manufacturing Market Research Report | NAICS 32541a | Dec 2013

Favorable prognosis: Healthcare reform and a focus on biologic drugs will keep demand afloat

IBISWorld’s Brand Name Pharmaceutical Manufacturing market research report can be used to help you: understand market size and growth potential; major companies; draft business plans and pitch books; and conduct benchmarking and SWOT analysis. Our industry analysis highlights macro industry trends in the overall sector and micro trends faced by companies that do business in the industry. The industry report also provides key industry statistics and 5-year forecasts to anticipate future industry prospects so you can decide with confidence.

Report Snapshot
Industry Statistics & Market Size
Revenue
$165bn
Annual Growth 08-13
-1.5%
Annual Growth 13-18
Add to Cart
Profit
Add to Cart
Employment
195,789
Businesses
1,575
Industry Analysis & Industry Trends

With healthcare reform allowing more individuals to gain prescription coverage, brand-name pharmaceutical and medicine manufacturers will experience a boost in demand. Rising production of branded follow-on biologic drugs will be important in offsetting the effects of widespread patent expirations, though a major increase in taxes and discounts to fill the Medicare coverage gap threatens profit in the industry... purchase to read more

Industry Report - Industry Analysis Chapter

Demand for Brand Name Pharmaceutical Manufacturing industry products has been boosted by an aging population and the use of prescription drugs as an integral part of US healthcare. Despite these favorable trends, the industry has suffered alongside the rest of the economy, with numerous brand blockbusters losing patent exclusivity, reducing revenue 8.5% in 2010.

Revenue is expected to slightly increase at an average annual rate of 1.5% to $165.0 billion during the five years to 2013, although revenue will drop 2.0% in 2013 as the industry's major players cope with losing patent protection for top-selling drugs. The number of new drugs reaching the market has been falling, driving industry players to focus on different areas of production to increase sales... purchase to read more

 


Industry ProductsRelated ReportsTable of Contents

What is the Brand Name Pharmaceutical Manufacturing Industry?

Pharmaceutical manufacturers develop prescription and over-the-counter products that are used to prevent or treat illnesses in humans or animals. Brand-name drugs and medication have patent protection. This industry does not include nutritional supplement or cosmetic product manufacturers.

Industry Products
Other pharmaceutical preparationsBiological productsOncological productsMedicinal and botanical productsRespiratory agentsLipid regulatorsAntidiabeticsIn-vitro diagnostic substances
 
Industry Activities
Pharmaceutical research and developmentManufacturing active ingredients used in pharmaceuticalsManufacturing chemical pharmaceutical preparationsManufacturing biological pharmaceutical products


View Sample
Quote
Select Clients